期刊文献+

二甲双胍对肾癌细胞凋亡的影响及机制 被引量:8

Effect of metformin on apoptosis of renal cell carcinoma cells in vitro and its mechanisms
下载PDF
导出
摘要 目的探讨二甲双胍对肾癌细胞凋亡的影响及其机制。方法通过Annexin V-FITC/PI染色镜下观察及流式细胞仪检测观察二甲双胍对786-O细胞凋亡的影响,通过免疫印迹检测AMPK信号及Caspase 9表达探讨可能分子机制。结果二甲双胍能够诱导786-O在低浓度血清环境凋亡,激活Caspase 9,二甲双胍能够激活786-O细胞中AMPK信号,但与其凋亡诱导效应无关。结论二甲双胍能够诱导肾癌细胞在低浓度血清环境凋亡,具有潜在治疗肾癌作用。 Objective To evaluate the effect of metformin on the apoptosis of renal cell carcinoma(RCC) cells in vitro and its mechanisms.Methods Fluorescent microscopy and flow cytometry were used to examine the changes in the apoptosis of 786-O cells after metformin treatment.The possible signaling molecules involved in this process were analyzed by immunoblot analysis of AMP-activated protein kinase(AMPK) signaling and caspase 9.Results Metformin induced apoptosis and caspase 9 activation in 786-O cells in low-serum medium but not in normal-serum medium.Metformin also induced AMPK activation in 786-O cells,but this activation was not associated with the cell proliferation inhibition or apoptosis-inducing effect of metformin.Conclusion Metformin can induce apoptosis of RCC cells in vitro,suggesting its potential as a therapeutic agent for RCC.
出处 《南方医科大学学报》 CAS CSCD 北大核心 2011年第9期1504-1508,共5页 Journal of Southern Medical University
基金 国家自然科学基金(31000633)~~
关键词 二甲双胍 肾细胞癌 细胞增殖 细胞凋亡 AMPK renal cell carcinoma metformin cell proliferation apoptosis AMP-activated protein kinase
  • 相关文献

参考文献1

共引文献44

同被引文献68

  • 1Bex A,Jonasch E,Kirkali Z. Integrating surgery with targeted therapies for renal cell carcinoma:current evidence and ongoing trials[J].{H}EUROPEAN UROLOGY,2010,(6):819-828.
  • 2Basso M,Cassano A,Barone C. A survey of therapy for advanced renal cell carcinoma[J].{H}Urologic Oncology,2010,(2):121-133.
  • 3Lam J S,Leppert J T,Belldegrun A S. Novel approaches in the therapy of metastatic renal cell carcinoma[J].{H}WORLD Journal OF UROLOGY,2005,(3):202-212.
  • 4Motzer R J,Russo P. Systemic therapy for renal cell carcinoma[J].{H}Journal Of Urology,2000,(2):408-417.
  • 5Thillai K,Allan S,Powles T. Neoadjuvant and adjuvant treatment of renal cell carcinoma[J].{H}EXPERT REVIEW OF ANTICANCER THERAPY,2012,(6):765-776.
  • 6Evans J M,Donnetly L A,Emslie-Smith A M. Metformin and reduced risk of cancer in diabetic patients[J].{H}BMJ:British Medical Journal,2005,(7503):1304-1305.
  • 7Bodmer M,Meier C,Krahenbuhl S. Long-term metformin use is associated with decreased risk of breast cancer[J].{H}DIABETES CARE,2010,(6):1304-1308.
  • 8Ben Sahra I,Laurent K,Loubat A. The antidiabetic drug metformin exerts an antitumoral effect in vitro and in vivo through a decrease of cyclin D1 level[J].{H}ONCOGENE,2008,(25):3576-3586.
  • 9Kisfalvi K,Eibl G,Sinnett-Smith J. Metformin disrupts crosstalk between G protein-coupled receptor and insulin receptor signaling systems and inhibits pancreatic cancer growth[J].{H}CANCER RESEARCH,2009,(16):6539-6545.
  • 10Karnevi E,Said K,Andersson R. Metforminmediated growth inhibition involves suppression of the IGF-I receptor signalling pathway in human pancreatic cancer cells[J].{H}BMC Cancer,2013.235.

引证文献8

二级引证文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部